Publication Name	World Journal of Neurology
Manuscript ID	4435
Country	Italy

Received	2013-06-29 19:39
Peer-Review Started	2013-06-29 21:10
To Make the First Decision	2013-07-19 08:35
Return for Revision	2013-07-20 23:06
Revised	2013-10-08 02:26
Second Decision	2013-10-17 13:21
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2013-10-18 07:11
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2013-12-19 18:59
Publish the Manuscript Online	2014-01-16 17:21

ISSN	2218-6212 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Clinical Neurology
Manuscript Type	Review
Article Title	Secondary prevention of ischaemic stroke
Manuscript Source	Invited Manuscript
All Author List	Irene Volonghi, Alessandro Padovani, Elisabetta Del Zotto, Alessia Giossi, Paolo Costa, Andrea Morotti, LorisPoli and Alessandro Pezzini
Funding Agency and Grant Number
Corresponding Author	Irene Volonghi, MD, Dipartimento di Scienze Cliniche e Sperimentali, Clinica Neurologica, Università degli Studi di Brescia, P.le Spedali Civili 1, 25123 Brescia, Italy. irene.volonghi@hotmail.it
Key Words	Stroke; Transient ischaemic attack; Secondary prevention; Antiplatelets; Anticoagulants; Medical stroke treatment; Carotid stenosis
Core Tip	Aggressive and combination treatments in the acute phase after transient ischaemic attack or minor stroke have been shown to be beneficial in few studies, but results of ongoing randomized trials are required. On the other side, in long-term prevention the most important innovation is the advent of new anticoagulant agents for stroke prevention in atrial fibrillation. Recent trials showed efficacy and safety of thrombin and factor Xa inhibitors, compared to vitamin K antagonists, whose use is hampered by several limitations. These new drugs will potentially increase the number of patients treated according to guidelines, thus preventing a remarkable proportion of strokes.
Publish Date	2014-01-16 17:21
Citation	Volonghi I, Padovani A, Del Zotto E, Giossi A, Costa P, Morotti A, Poli L, Pezzini A. Secondary prevention of ischaemic stroke. World J Neurol 2013; 3(4): 97-114
URL	http://www.wjgnet.com/2218-6212/full/v3/i4/97.htm
DOI	http://dx.doi.org/10.5316/wjn.v3.i4.97

Full Article (PDF)	WJN-3-97.pdf
Full Article (Word)	WJN-3-97.doc
Manuscript File	4435-Review.doc
Answering Reviewers	4435-Answering reviewers.pdf
Copyright License Agreement	4435-Copyright assignment.pdf
Peer-review Report	4435-Peer review(s).pdf
Scientific Editor Work List	4435-Scientific editor work list.doc